Results 231 to 240 of about 20,357,001 (365)

Potential of <i>Aeginetia indica</i> for Alzheimer's Disease Management: In Vitro, In Vivo, and Computational Insights. [PDF]

Food Sci Nutr
Bhuiyan MR, Reza MS, Shuvo SR, Yilmaz MA, Siam SMM, Sakib MS, Cakir O, Durjoy MNI, Tarhan A, Eruygur N, Shahid Ud Daula AFM.   +10 more
europepmc   +1 more source

COMET: a multicomponent home-based disease-management programme versus routine care in severe COPD

European Respiratory Journal, 2018
R. Kessler, P. Casàn-Clará, D. Koehler, S. Tognella, J. Viejo, R. D. Dal Negro, S. Díaz-Lobato, Karina Reissig, J. M. Rodríguez González-Moro, G. Devouassoux, J. Chavaillon, P. Botrus, J. Arnal, J. Ancochea, A. Bergeron-Lafaurie, C. de Abajo, W. Randerath, A. Bastian, C. Cornelissen, G. Nilius, J. Texereau, J. Bourbeau   +21 more
semanticscholar   +1 more source

Risk of Non‐Arteritic Anterior Ischemic Optic Neuropathy in Idiopathic Intracranial Hypertension Patients Treated with GLP‐1 Receptor Agonists

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Introduction Glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) have demonstrated significant weight‐reducing effects and may offer benefits in idiopathic intracranial hypertension (IIH); however, recent concerns about the risk of non‐arteritic anterior ischemic optic neuropathy (NAION) have emerged.
Faisal A. Al‐Harbi, Mohanad A. Alkuwaiti, Yazeed B. Alaql, Ahmed K. Alsaif, Ahmed A. Alessa, Meshari Ayed Alharbi, Mohammed Alfalah, Saud A. Alnaaim, Sajjad M. AlHaddad, Ahmed Y. Azzam   +9 more
wiley   +1 more source

Loneliness in Chronic Obstructive Pulmonary Disease: A Multidimensional Determinant of Clinical Outcomes and Disease Management. [PDF]

J Clin Med
Mengash A, Siraj RA.
europepmc   +1 more source

Sertraline Treatment Can Mimic Niemann‐Pick Type C Biomarker Profile: A Diagnostic Pitfall

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Oxysterols (cholestane‐3β,5α,6β‐triol and 7‐ketocholesterol) and N‐palmitoyl‐O‐phosphocholineserine (PPCS) are sensitive biomarkers for Niemann‐Pick disease type C (NPC) screening. However, false‐positive results occur, with a biomarker profile suggestive of NPC despite the absence of pathogenic variants in genes involved in NPC or ...
Maria Makrygianni, Cecile Pagan, Antony Citterio‐Quentin, Isabelle Rouvet, Giulia Dingeo, Cyril Hanin, Claudine Laurent‐Levinson, Samia Pichard, Bénédicte Héron, Clément Gourguechon, Daniele Mandia, Jerome Guitton, Carole Lacout, Nicolas Schleinitz, Florient Potier, Olivier Flabeau, Elsa Besse‐Pinot, Foudil Lamari, Magali Pettazzoni, Yann Nadjar   +19 more
wiley   +1 more source

Invasive Species Management: Foot-and-Mouth Disease in the U.S. Beef Industry

A conceptual bioeconomic framework that integrates dynamic epidemiological-economic processes was designed to analyze the effects of invasive species introduction on decision making in a livestock sector (e.g., production and feeding).
Zhao, Zishun, Wahl, Thomas I., Marsh, Thomas L.   +2 more
core  

Unburdening healthcare systems through telenursing in chronic respiratory disease management: a systematic review. [PDF]

Front Digit Health
Vatrella A, Maglio AA, Di Palo MP, Garofano M, Falco A, Ragusa CM, Andretta V, Pessolano C, Marino A, Calabrese M, Bramanti A.   +10 more
europepmc   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

Evidence-Based Laboratory Medicine for Cardiovascular Disease Management in Mental Healthcare: A Literature Review. [PDF]

Cureus
Kyelu BA, Bwititi PT, Sharma S, Nwose EU.   +3 more
europepmc   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source